Personalization of Clotting Factor VIII Replacement Therapy Based on Population Pharmacokinetics in Adult Patients with Severe Hemophilia a Who Frequently Switch Factor VIII Concentrates

被引：0

作者：

Windyga, Jerzy ^{[1
]}

Odnoczko, Edyta ^{[2
]}

Stefanska-Windyga, Ewa ^{[3
]}

Baran, Beata ^{[2
]}

Sikorska, Anna ^{[3
]}

Gorska-Kosicka, Magdalena ^{[4
]}

Zawilski, Janusz ^{[5
]}

Letowska, Magdalena ^{[6
]}

机构：

[1] Inst Hematol & Transfus Med, Dept Hemostasis Disorders & Internal Med, Lab Hemostasis & Metab Dis, Warsaw, Poland

[2] Inst Hematol & Transfus Med, Lab Hemostasis & Metab Dis, Warsaw, Poland

[3] Inst Hematol & Transfus Med, Clin Hemostasis Disorders, Warsaw, Poland

[4] Inst Hematol & Transfus Med, Dept Hemostasis Disorders & Internal Med, Warsaw, Poland

[5] INTERLAB, Poznan, Poland

[6] Inst Hematol & Transfus Med, Dept Transfus Med, Warsaw, Poland

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-164998

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：8451 / 8452

页数：2

共 50 条

[1] Pharmacokinetics of Continuous Infusion Therapy of Factor VIII Concentrates in Hemophilia A Patients with Inhibitors
Nishiya, Katsumi
Tanaka, Ichiro
Nogami, Keiji
Ogiwara, Kenichi
Yada, Koji
Matsumoto, Tomoko
Shima, Midori
BLOOD, 2011, 118 (21) : 1428 - 1428
[2] Pharmacokinetics of factor VIII concentrates in subjects with hemophilia A who are Bethesda negative for factor VIII inhibitors and ELISA positive for antibodies reacting with different factor VIII preparations
Rivard, G.
Dedeken, L.
Vincent, A.
Lillicrap, D.
Meilleur, C.
Fan, L.
HAEMOPHILIA, 2010, 16 : 71 - 71
[3] Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
Tim Preijers
Lisette M. Schütte
Marieke J. H. A. Kruip
Marjon H. Cnossen
Frank W. G. Leebeek
Reinier M. van Hest
Ron A. A. Mathôt
Clinical Pharmacokinetics, 2021, 60 : 1 - 16
[4] Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
Preijers, Tim
Schutte, Lisette M.
Kruip, Marieke J. H. A.
Cnossen, Marjon H.
Leebeek, Frank W. G.
van Hest, Reinier M.
Mathot, Ron A. A.
CLINICAL PHARMACOKINETICS, 2021, 60 (01) : 1 - 16
[5] Population pharmacokinetics of recombinant coagulation factor VIII-SingleChain in patients with severe hemophilia A
Zhang, Y.
Roberts, J.
Tortorici, M.
Veldman, A.
St Ledger, K.
Feussner, A.
Sidhu, J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (06) : 1106 - 1114
[6] POPULATION PHARMACOKINETICS OF RECOMBINANT FACTOR VIII (REFACTO®) IN ADULT HEMOPHILIA PATIENTS UNDER PROPHYLAXIS
Karafoulidou, A.
Suarez, E.
Anastasopoulou, I.
Katsarou, O.
Kouramba, A.
Kotsi, P.
Zografidis, A.
Lukas, J. C.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2008, 30 : 145 - 145
[7] Replacement therapy with virus-inactivated clotting factor concentrates in patients with severe hemophilia in Heidelberg
Zimmermann, R
Uhle, C
Huth-Kühne, A
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 : 75 - 78
[8] Dynamics of plasma factor VIII during the continuous infusion of factor VIII concentrates in twenty patients with hemophilia A
Nishiya, K.
Nogami, K.
Tanaka, I
Shibata, M.
Ogiwara, K.
Matsumoto, T.
Shima, M.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 929 - 930
[9] Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of Recombinant Factor VIII replacement therapy
Giles, AR
Rivard, GE
Teitel, J
Walker, I
TRANSFUSION SCIENCE, 1998, 19 (02): : 139 - 148
[10] Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A
Chen, Zhenping
Huang, Kun
Li, Gang
Zhen, Yingzi
Wu, Xinyi
Ai, Di
Liu, Guoqing
Li, Zekun
Alfonso, Iorio
Wu, Runhui
PEDIATRIC INVESTIGATION, 2021, 5 (01) : 38 - 45

← 1 2 3 4 5 →